|
|
 |
| |
|
Home > Drug Companies > Bausch & Lamb Pharmaceuticals
Bausch & Lamb Pharmaceuticals
Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York. Bausch & Lomb's 2004 revenues were $2.2 billion; it employs approximately 12,400 people worldwide and its products are available in more than 100 countries.
The Company offers a comprehensive line of products for ophthalmic surgery and is dedicated to continued innovation. By providing a complete procedural approach to vision care and continuing to develop innovative products, educational programs, and partnership programs, they are carrying out its commitment to help transform surgical technique and enhance the quality of vision for people around the world.
Bausch & Lomb's vision care business manufactures and markets the world's most comprehensive line of eye care products. Soft and GP gas permeable contact lenses, Lens care products for soft and GP lenses, Eye care products, such as eye drops and ointments, and Vision accessories, such as magnifiers and eyeglass accessories.
The Company develops and markets prescription and over the counter drugs used to treat a wide range of eye conditions, including glaucoma, eye allergies, conjunctivitis, and dry eye. Their company extends far beyond products. Use the links below to discover more about their history, their goals, and a Bausch & Lomb program to honor outstanding high school students.
At Bausch & Lomb, they strive to create long term value for their shareholders. As you explore this section, you will find facts, figures and financial information that illustrate their operating philosophy, detail their past performance, present their current status and demonstrate how they will continue to create value in the future.
Back to Drug Companies
|
|
|
|
|
|
|
|